Research & Reviews in Science and Mathematics, PROF.DR.HASAN AKGÜL, Editör, GECE KİTAPLIĞI, Ankara, ss.1-20, 2021
Cancer, the uncontrolled growth of abnormal cells called cancer
cells, malignant cells or tumor cells anywhere in the body, is the second
most common cause of death worldwide, killing more than 8 million
people each year. The most common types of cancer that cause death
are lung, stomach, liver, colon and breast cancer. With an estimated 13.1
million deaths (an increase of about 70%) in 2030, cancer deaths are
projected to continue to rise worldwide.
Many natural and synthetic compounds have been used in cancer
treatment for years. Coumarin compounds are also one of the compounds
used (Borges et al., 2013). Psoralen (or 7H-furo [3,2-g]chromen-7-one)
is a furanocoumarin that exhibits anti-arthritic, antimicrobial and antiinflammatory
effects (Asif, 2015). On the other hand, esculetin the
IUPAC name of which is 6,7-dihydroxy-2H-chromen-2-one has been
reported to protect single-cell DNA from oxidative attack (Aneko
et al., 2007). Esculetin is propitious to regulate vasoconstriction by
diminishing the release of nitric oxide (Liang et al., 2017), it overcomes
the Sp1 transcription factor (Liang et al., 2017) and binds with β-catenin
proteins resulting in the inhibition of β-catenin–Tcf signaling pathway
of gastrointestinal tumorigenesis (Lee et al., 2013) and it also inhibits
melanin biosynthesis (Sollai et al., 2008). New coumarin compounds are
added to the literature every year as anticancer agents. Coumarins are
heterocyclic compounds belonging to the class of benzopyrone and the
breakdown of them results in the formation of active metabolites with
therapeutic activity, such molecules are called as pro-drugs (Stefanachi
et al., 2018). Therefore they have a lot of bioactive properties such as
anticoagulant, antibacterial, anti-inflammatory, antioxidant, antitumor,
antiviral, and enzyme inhibition. Higher doses of coumarin are found
to be hepatotoxic (Iwata et al., 2016).